OPVALNU
LIVE

Serial Number

99692918

Owner

Glaxo Group Limited

Attorney

Christopher M. Hanes

Filing Date

Mar 10, 2026

Add to watchlist:

No watchlists yet
View on USPTO

OPVALNU Trademark

Serial Number: 99692918

OPVALNU is a trademark filed by Glaxo Group Limited on March 10, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glaxo Group Limited (135 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

March 10, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 24, 2026 ERSI
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 24, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 24, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 24, 2026 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 19, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 19, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jun 19, 2026 CNSL
ASSIGNED TO EXAMINER
Jun 18, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 10, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2026 NWOS
NEW APPLICATION ENTERED
Mar 10, 2026 NWAP